Van de Kar LD - Search Results

1

Neuroendocrine pharmacology of three serotonin releasers: 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butane (MBDB), 5-methoxy-6-methyl-2-aminoindan (MMAi) and p-methylthioamphetamine (MTA).

Li Q, Murakami I, Stall S, Levy AD, Brownfield MS, Nichols DE, Van de Kar LD. Li Q, et al. Among authors: van de kar ld. J Pharmacol Exp Ther. 1996 Dec;279(3):1261-7. J Pharmacol Exp Ther. 1996. PMID: 8968349

2

Neuroendocrine profile of the potential anxiolytic drug S-20499.

Levy AD, Li Q, Gustafson M, Van de Kar LD. Levy AD, et al. Among authors: van de kar ld. Eur J Pharmacol. 1995 Feb 14;274(1-3):141-9. doi: 10.1016/0014-2999(94)00719-n. Eur J Pharmacol. 1995. PMID: 7768266

3

Hypothalamic paraventricular, but not supraoptic neurons, mediate the serotonergic stimulation of oxytocin secretion.

Van de Kar LD, Rittenhouse PA, Li Q, Levy AD, Brownfield MS. Van de Kar LD, et al. Brain Res Bull. 1995;36(1):45-50. doi: 10.1016/0361-9230(94)00161-s. Brain Res Bull. 1995. PMID: 7882048

4

Repeated cocaine exposure inhibits the adrenocorticotropic hormone response to the serotonin releaser d-fenfluramine and the 5-HT1A agonist, 8-OH-DPAT.

Levy AD, Li Q, Van de Kar LD. Levy AD, et al. Among authors: van de kar ld. Neuropharmacology. 1994 Mar-Apr;33(3-4):335-42. doi: 10.1016/0028-3908(94)90063-9. Neuropharmacology. 1994. PMID: 7984271

5

Attenuation of hormone responses to the 5-HT1A agonist ipsapirone by long-term treatment with fluoxetine, but not desipramine, in male rats.

Li Q, Brownfield MS, Levy AD, Battaglia G, Cabrera TM, Van de Kar LD. Li Q, et al. Among authors: van de kar ld. Biol Psychiatry. 1994 Sep 1;36(5):300-8. doi: 10.1016/0006-3223(94)90627-0. Biol Psychiatry. 1994. PMID: 7993956

6

Evidence that ACTH secretion is regulated by serotonin2A/2C (5-HT2A/2C) receptors.

Rittenhouse PA, Bakkum EA, Levy AD, Li Q, Carnes M, van de Kar LD. Rittenhouse PA, et al. Among authors: van de kar ld. J Pharmacol Exp Ther. 1994 Dec;271(3):1647-55. J Pharmacol Exp Ther. 1994. PMID: 7996480

7

ICV injection of the serotonin 5-HT1B agonist CP-93,129 increases the secretion of ACTH, prolactin, and renin and increases blood pressure by nonserotonergic mechanisms.

Van de Kar LD, Alvarez Sanz MC, Yracheta JM, Kunimoto K, Li Q, Levy AD, Rittenhouse PA. Van de Kar LD, et al. Pharmacol Biochem Behav. 1994 Jun;48(2):429-36. doi: 10.1016/0091-3057(94)90548-7. Pharmacol Biochem Behav. 1994. PMID: 8090811

8

Long-term fluoxetine, but not desipramine, inhibits the ACTH and oxytocin responses to the 5-HT1A agonist, 8-OH-DPAT, in male rats.

Li Q, Levy AD, Cabrera TM, Brownfield MS, Battaglia G, Van de Kar LD. Li Q, et al. Among authors: van de kar ld. Brain Res. 1993 Dec 10;630(1-2):148-56. doi: 10.1016/0006-8993(93)90652-4. Brain Res. 1993. PMID: 8118681

9

Repeated exposure to cocaine produces long-lasting deficits in the serotonergic stimulation of prolactin and renin, but not adrenocorticotropin secretion.

Levy AD, Rittenhouse PA, Bonadonna AM, Alvarez Sanz MC, Bethea CL, Van de Kar LD. Levy AD, et al. Among authors: van de kar ld. Eur J Pharmacol. 1993 Sep 14;241(2-3):275-8. doi: 10.1016/0014-2999(93)90215-4. Eur J Pharmacol. 1993. PMID: 8243563

10

Long-term treatment with the antidepressants fluoxetine and desipramine potentiates endocrine responses to the serotonin agonists 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212) and (+-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane HCl (DOI).

Li Q, Brownfield MS, Battaglia G, Cabrera TM, Levy AD, Rittenhouse PA, van de Kar LD. Li Q, et al. Among authors: van de kar ld. J Pharmacol Exp Ther. 1993 Aug;266(2):836-44. J Pharmacol Exp Ther. 1993. PMID: 8394920

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

144 results

Search Page